Email
Print
Cytogenetics Market Overview
Cytogenetics
Market size was estimated at $2.6 billion in 2020, projected to grow at a CAGR
of 9.2% during the forecast period 2021-2026. Cytogenetics industry has
witnessed huge demand owing to the technological advancements along with
increasing usage of pharmacogenomics for several personalised disease and drug
development. The branch of genetics that studies the structure of DNA inside
the cell nucleus is called cytogenetics. During cell division, DNA gets condensed
and forms chromosomes.
The pairing of homologous chromosomes is known as
karyotyping or chromosome analysis. An abnormality where in a chromosome breaks
and a portion of it attaches to a different chromosome is known as chromosomal
translocation. It is detected by analysing karyotypes of the affected cells.
The cytogenetic study is used to better understand the genetic diseases like down
syndrome, sickle cell anaemia, cancer, cystic fibrosis and others. Moreover,
Cytogenetics is effectively used in development of cancer treatment,
personalised medicine.
Rising prevalence of cancer and other genetic disorders each year is significantly driving the market growth. According to WHO, in the year 2018 around 18.1 million new cases were diagnosed and 9.6 million individuals died out of cancer. For screening genetic disorders and cancers, various techniques such as karyotyping, comparative genomic hybridization and Fluorescence in situ hybridization are currently used. Where, Comparative genomic hybridization and Fluorescence in situ hybridization are the most recognised cytogenetics techniques and provides information regarding cancer.
Report Coverage
The report: “Cytogenetics Market Forecast (2021-2026)”,
by Industry ARC, covers an in-depth analysis of the following segments of the Cytogenetics Market.
By Product Type: Instruments, Consumables, Software & Services.
By Technique: Karyotyping, Comparative genomic hybridization, Fluorescence in situ hybridization (FISH), Immunohistochemistry and Others.
By Application: Cancer, Genetic Disorders, Personalised Medicine and others.
By End User: Biotechnology & Pharmaceutical Companies, Clinical & Research Laboratories, Academic Research Institutes.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America), and Rest of the World (Middle East and Africa).
Key Takeaways
- Geographically, North America Cytogenetics Market held the largest revenue share of 39% in 2020 owing to the highest disposable income and growing geriatric population in this region.
- According to WHO 2.26 million new cases of breast cancer was reported in the year 2020.
- Increase in prevalence of breast cancer, growing medical tourism in various developing countries are the other factors boosting the market growth and provide lucrative growth opportunities for the global market expansion.
Cytogenetics Market: Market Share (%) by Region, 2020
For More Details on This Report - Request for Sample
Cytogenetics Market Segment Analysis – By Technique:
Based on Deployment, Cytogenetics Market is segmented into Karyotyping, Comparative genomic hybridization, Fluorescence in situ
hybridization (FISH), Immunohistochemistry and Others. Comparative genomic hybridization segment is accounted
for the largest revenue market share in 2020 owing to its crucial role in
significant cancer studies. Comparative genomic hybridization’s key benefit is that it can
identify DNA sequence copy number changes across the genome in a single
hybridization, and it can map these often complex changes onto regular metaphase
chromosomes.
Fluorescence in situ hybridization segment is poised to
grow with the fastest CAGR of 9.7% in the forecast period 2021-2026 owing to
its benefits such as precision in identifying targeted DN or RNA sequences,
high sensitivity, direct application on metaphase chromosome and also
interphase. Moreover, it is used to visualize the specific genes and to test
the breast cancer tissue that is removed during biopsy to check whether the
cells have extra copies of the gene HER2.
Cytogenetics Market Segment Analysis – By Application:
Based on Application, Cytogenetics
Market is segmented into Cancer, Genetic Disorders, Personalised Medicine and others. Cancer
segment held largest market share
in 2020 owing to the ongoing developments and growing prevalence of cancer
globally. According to the U.S. Breast Cancer
Statistics, 1 in every 8 U.S. women develops invasive breast cancer in their
life time. Various advantages of cytogenetics such as rapid and accurate
diagnosis, recurrence estimation along with survival prediction of a cancer
patient are the major factors driving the market.
Personalised Medicine is predicted to grow
with the fastest CAGR of 9.9% in the forecast period 2021-2026 as it is
considered to be the most effective method for achieving better patient
results. The use of molecular cytogenetic techniques is expected to expand
lucratively over the forecast era, owing to a trend toward personalized
medicine. This is owing to the fact that molecular cytogenetic research has a
broad range of applications in personalized medicine, including cytoproteomics,
cytogenomics, drug discovery and growth, and biomarker discovery.
Cytogenetics Market Segment Analysis – Geography:
Based on Geography, North America Cytogenetics Market accounted
for the 39% revenue share in 2020. This is majorly attributed to the
technological advancement and presence of key market players and rising prevalence
of Cancer in this region. For instance, according to
breast cancer organization, the U.S is estimated to have 281,550 new breast
cancer cases in 2021 among women and breast cancer is considered as the most
common cancer diagnosed.
Asia-Pacific market
is poised to grow with the fastest CAGR in the
forecast period 2021-2026 owing its increasing health care expenditure coupled
with advancements in healthcare infrastructure. According to National Cancer
Registry Program, India, the patients with cancer in India is estimated to be
679,421 males and 712,758 females in 2020. 1 in every 68 males and 1 in every
29 females develop cancer during their lifetime. Moreover, advancements in
human genetics along with disease management aid to market growth.
Cytogenetics Market Drivers
Technological Advancements in Molecular Cytogenetics:
Over
the forecast period, increasing acceptance of molecular cytogenetics is
expected to drive the global molecular cytogenetics market. For example,
Bionano Genomics, Inc. reported in October 2019 that Saphyr has been adopted by
leading organizations such as PerkinElmer Genomics and the University of Iowa
for use in their clinical genomics laboratories. Furthermore, the rising
prevalence of cancer is expected to increase the use of molecular cytogenetics.
Increasing prevalence of Cancer:
As the
number of cancer cases rises, various molecular cytogenetics methods are
becoming more widely used for diagnostic purposes. Apart from that, the
increase in cancer research is fueling the growth of the cytogenetics
industry, as advanced techniques are needed to better understand cancer at the
chromosomal level. FISH and CGH techniques, for example, provide critical
knowledge about cancer-related molecular signatures, resulting in market
development. In the construction of genetic, physical, molecular, and
comparative maps, FISH, chromosome image analysis, flow sorting, and genomic
in-situ hybridization (GISH), which were developed for the production of
artificial plant chromosomes, are used. Their achievements have paved the way
for the introduction of a variety of breeding methods. Furthermore, the FISH
technique is being used in various studies for the characterization of alien
segments; thus, the growing application field and benefits of molecular
cytogenetics in crop improvement are aiding the market's development.
Cytogenetics Market Challenges
Undesirable Reimbursement Policies:
Unflattering reimbursement policies are
a big stumbling block to the global molecular cytogenetics market's expansion.
Molecular diagnostic tests are not being reimbursed by insurance providers. Furthermore,
the high cost of genetic testing is likely to stifle market expansion. These
tests are considered the most effective technologies for early detection, with
prices ranging from $300 to $3,000 per test.
Cytogenetics Market Segment Landscape:
Product launches, mergers and acquisitions, joint ventures and
geographical expansions are key strategies adopted by players in the Cytogenetics Market. Cytogenetics Market top
10 companies are Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La
Roche Ltd., Thermo Fisher Scientific, Inc., Agilent Technologies, Applied
Spectral Imaging, Abbott Laboratories., Illumina, Inc., Oxford Gene Technology,
PerkinElmer, Inc.
Acquisitions/Product Launches:
- In March 2020, Agilent Technologies Inc., has introduced three new microarrays to meet the requirement of cytogenetics laboratories that conduct prenatal and postnatal research.
Related Reports:
Report Code:
HCR 81207
Report Code:
HCR 16544
1. Cytogenetics Market - Overview
1.1 Definitions and Scope
2. Cytogenetics Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Product Type
2.3 Key trends by Technique
2.4 Key trends by Application
2.5 Key trends by End User
2.6 Key trends by Geography
3. Cytogenetics Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split - Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis – Average Selling Price
4. Cytogenetics Market - Startup Companies Scenario Premium
4.1 Key Startup Company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Venture Capital and Funding Scenario
5. Cytogenetics Market – Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Cytogenetics Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Cytogenetics Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Cytogenetics Market – By Product Type (Market Size –$Million/$Billion)
8.1 Instruments
8.2 Consumables
8.3 Software & Services
9. Cytogenetics Market – By Technique(Market Size –$Million/$Billion)
9.1 Karyotyping
9.2 Comparative Genomic Hybridization
9.3 Fluorescence in situ hybridization (FISH)
9.4 Immunohistochemistry
9.5 Others
10. Cytogenetics Market – By Application (Market Size –$Million/$Billion)
10.1 Biotechnology & Pharmaceutical Companies
10.2 Clinical & Research Laboratories
10.3 Academic Research Institutes
11. Cytogenetics Market – By End User(Market Size –$Million/$Billion)
11.1 Hospitals
11.2 Ambulatory Surgical Centers
11.3 Cell & Tissue banks
11.4 Biotech Companies
11.5 Research Institutes
11.6 Academic Institutes
11.7 Contract Research Organizations
12. Cytogenetics Market - By Geography(Market Size –$Million/$Billion)
12.1 North America
12.1.1 U.S.
12.1.2 Mexico
12.1.3 Canada
12.2 Europe
12.2.1 U.K.
12.2.2 France
12.2.3 Germany
12.2.4 Italy
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Asia Pacific
12.3.1 China
12.3.2 India
12.3.3 Japan
12.3.4 South Korea
12.3.5 Australia & New Zealand
12.3.6 Rest of APAC
12.4 South America
12.4.1 Brazil
12.4.2 Argentina
12.4.3 Rest of South America
12.5 Rest of the World
12.5.1 Middle East
12.5.2 Africa
13. Cytogenetics Market - Entropy
14. Cytogenetics Market – Industry/Segment Competition Landscape Premium
14.1 Market Share Analysis
14.1.1 Global Market Share – Key Companies
14.1.2 Market Share by Region – Key companies
14.1.3 Market Share by Countries – Key Companies
14.1.4 Best Practices for Companies
15. Cytogenetics Market – Key Company List by Country Premium Premium
16. Cytogenetics Market Company Analysis
16.1 Company 1
16.2 Company 2
16.3 Company 3
16.4 Company 4
16.5 Company 5
16.6 Company 6
16.7 Company 7
16.8 Company 8
16.9 Company 9
16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
LIST OF TABLES
1.Global CYTOGENETICS MARKET, BY PRODUCT Market 2023-2030 ($M)1.1 Consumable Market 2023-2030 ($M) - Global Industry Research
1.1.1 Testing kits, media, and reagents Market 2023-2030 ($M)
1.1.2 Probes Market 2023-2030 ($M)
1.2 Instrument Market 2023-2030 ($M) - Global Industry Research
1.3 Software service Market 2023-2030 ($M) - Global Industry Research
2.Global CYTOGENETICS MARKET, BY TECHNIQUE Market 2023-2030 ($M)
2.1 Comparitive genome hybridization Market 2023-2030 ($M) - Global Industry Research
2.2 Fluorescence in situ hybridization Market 2023-2030 ($M) - Global Industry Research
2.3 Karyotyping Market 2023-2030 ($M) - Global Industry Research
2.4 Immunohistochemistry Market 2023-2030 ($M) - Global Industry Research
3.Global CYTOGENETICS MARKET, BY END USER Market 2023-2030 ($M)
3.1 Clinical and research laboratory Market 2023-2030 ($M) - Global Industry Research
3.2 Pharmaceutical and biotechnology company Market 2023-2030 ($M) - Global Industry Research
3.3 Academic Research Institute Market 2023-2030 ($M) - Global Industry Research
4.Global CYTOGENETICS MARKET, BY PRODUCT Market 2023-2030 (Volume/Units)
4.1 Consumable Market 2023-2030 (Volume/Units) - Global Industry Research
4.1.1 Testing kits, media, and reagents Market 2023-2030 (Volume/Units)
4.1.2 Probes Market 2023-2030 (Volume/Units)
4.2 Instrument Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Software service Market 2023-2030 (Volume/Units) - Global Industry Research
5.Global CYTOGENETICS MARKET, BY TECHNIQUE Market 2023-2030 (Volume/Units)
5.1 Comparitive genome hybridization Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Fluorescence in situ hybridization Market 2023-2030 (Volume/Units) - Global Industry Research
5.3 Karyotyping Market 2023-2030 (Volume/Units) - Global Industry Research
5.4 Immunohistochemistry Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global CYTOGENETICS MARKET, BY END USER Market 2023-2030 (Volume/Units)
6.1 Clinical and research laboratory Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Pharmaceutical and biotechnology company Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 Academic Research Institute Market 2023-2030 (Volume/Units) - Global Industry Research
7.North America CYTOGENETICS MARKET, BY PRODUCT Market 2023-2030 ($M)
7.1 Consumable Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Testing kits, media, and reagents Market 2023-2030 ($M)
7.1.2 Probes Market 2023-2030 ($M)
7.2 Instrument Market 2023-2030 ($M) - Regional Industry Research
7.3 Software service Market 2023-2030 ($M) - Regional Industry Research
8.North America CYTOGENETICS MARKET, BY TECHNIQUE Market 2023-2030 ($M)
8.1 Comparitive genome hybridization Market 2023-2030 ($M) - Regional Industry Research
8.2 Fluorescence in situ hybridization Market 2023-2030 ($M) - Regional Industry Research
8.3 Karyotyping Market 2023-2030 ($M) - Regional Industry Research
8.4 Immunohistochemistry Market 2023-2030 ($M) - Regional Industry Research
9.North America CYTOGENETICS MARKET, BY END USER Market 2023-2030 ($M)
9.1 Clinical and research laboratory Market 2023-2030 ($M) - Regional Industry Research
9.2 Pharmaceutical and biotechnology company Market 2023-2030 ($M) - Regional Industry Research
9.3 Academic Research Institute Market 2023-2030 ($M) - Regional Industry Research
10.South America CYTOGENETICS MARKET, BY PRODUCT Market 2023-2030 ($M)
10.1 Consumable Market 2023-2030 ($M) - Regional Industry Research
10.1.1 Testing kits, media, and reagents Market 2023-2030 ($M)
10.1.2 Probes Market 2023-2030 ($M)
10.2 Instrument Market 2023-2030 ($M) - Regional Industry Research
10.3 Software service Market 2023-2030 ($M) - Regional Industry Research
11.South America CYTOGENETICS MARKET, BY TECHNIQUE Market 2023-2030 ($M)
11.1 Comparitive genome hybridization Market 2023-2030 ($M) - Regional Industry Research
11.2 Fluorescence in situ hybridization Market 2023-2030 ($M) - Regional Industry Research
11.3 Karyotyping Market 2023-2030 ($M) - Regional Industry Research
11.4 Immunohistochemistry Market 2023-2030 ($M) - Regional Industry Research
12.South America CYTOGENETICS MARKET, BY END USER Market 2023-2030 ($M)
12.1 Clinical and research laboratory Market 2023-2030 ($M) - Regional Industry Research
12.2 Pharmaceutical and biotechnology company Market 2023-2030 ($M) - Regional Industry Research
12.3 Academic Research Institute Market 2023-2030 ($M) - Regional Industry Research
13.Europe CYTOGENETICS MARKET, BY PRODUCT Market 2023-2030 ($M)
13.1 Consumable Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Testing kits, media, and reagents Market 2023-2030 ($M)
13.1.2 Probes Market 2023-2030 ($M)
13.2 Instrument Market 2023-2030 ($M) - Regional Industry Research
13.3 Software service Market 2023-2030 ($M) - Regional Industry Research
14.Europe CYTOGENETICS MARKET, BY TECHNIQUE Market 2023-2030 ($M)
14.1 Comparitive genome hybridization Market 2023-2030 ($M) - Regional Industry Research
14.2 Fluorescence in situ hybridization Market 2023-2030 ($M) - Regional Industry Research
14.3 Karyotyping Market 2023-2030 ($M) - Regional Industry Research
14.4 Immunohistochemistry Market 2023-2030 ($M) - Regional Industry Research
15.Europe CYTOGENETICS MARKET, BY END USER Market 2023-2030 ($M)
15.1 Clinical and research laboratory Market 2023-2030 ($M) - Regional Industry Research
15.2 Pharmaceutical and biotechnology company Market 2023-2030 ($M) - Regional Industry Research
15.3 Academic Research Institute Market 2023-2030 ($M) - Regional Industry Research
16.APAC CYTOGENETICS MARKET, BY PRODUCT Market 2023-2030 ($M)
16.1 Consumable Market 2023-2030 ($M) - Regional Industry Research
16.1.1 Testing kits, media, and reagents Market 2023-2030 ($M)
16.1.2 Probes Market 2023-2030 ($M)
16.2 Instrument Market 2023-2030 ($M) - Regional Industry Research
16.3 Software service Market 2023-2030 ($M) - Regional Industry Research
17.APAC CYTOGENETICS MARKET, BY TECHNIQUE Market 2023-2030 ($M)
17.1 Comparitive genome hybridization Market 2023-2030 ($M) - Regional Industry Research
17.2 Fluorescence in situ hybridization Market 2023-2030 ($M) - Regional Industry Research
17.3 Karyotyping Market 2023-2030 ($M) - Regional Industry Research
17.4 Immunohistochemistry Market 2023-2030 ($M) - Regional Industry Research
18.APAC CYTOGENETICS MARKET, BY END USER Market 2023-2030 ($M)
18.1 Clinical and research laboratory Market 2023-2030 ($M) - Regional Industry Research
18.2 Pharmaceutical and biotechnology company Market 2023-2030 ($M) - Regional Industry Research
18.3 Academic Research Institute Market 2023-2030 ($M) - Regional Industry Research
19.MENA CYTOGENETICS MARKET, BY PRODUCT Market 2023-2030 ($M)
19.1 Consumable Market 2023-2030 ($M) - Regional Industry Research
19.1.1 Testing kits, media, and reagents Market 2023-2030 ($M)
19.1.2 Probes Market 2023-2030 ($M)
19.2 Instrument Market 2023-2030 ($M) - Regional Industry Research
19.3 Software service Market 2023-2030 ($M) - Regional Industry Research
20.MENA CYTOGENETICS MARKET, BY TECHNIQUE Market 2023-2030 ($M)
20.1 Comparitive genome hybridization Market 2023-2030 ($M) - Regional Industry Research
20.2 Fluorescence in situ hybridization Market 2023-2030 ($M) - Regional Industry Research
20.3 Karyotyping Market 2023-2030 ($M) - Regional Industry Research
20.4 Immunohistochemistry Market 2023-2030 ($M) - Regional Industry Research
21.MENA CYTOGENETICS MARKET, BY END USER Market 2023-2030 ($M)
21.1 Clinical and research laboratory Market 2023-2030 ($M) - Regional Industry Research
21.2 Pharmaceutical and biotechnology company Market 2023-2030 ($M) - Regional Industry Research
21.3 Academic Research Institute Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Cytogenetics Market Revenue, 2023-2030 ($M)2.Canada Cytogenetics Market Revenue, 2023-2030 ($M)
3.Mexico Cytogenetics Market Revenue, 2023-2030 ($M)
4.Brazil Cytogenetics Market Revenue, 2023-2030 ($M)
5.Argentina Cytogenetics Market Revenue, 2023-2030 ($M)
6.Peru Cytogenetics Market Revenue, 2023-2030 ($M)
7.Colombia Cytogenetics Market Revenue, 2023-2030 ($M)
8.Chile Cytogenetics Market Revenue, 2023-2030 ($M)
9.Rest of South America Cytogenetics Market Revenue, 2023-2030 ($M)
10.UK Cytogenetics Market Revenue, 2023-2030 ($M)
11.Germany Cytogenetics Market Revenue, 2023-2030 ($M)
12.France Cytogenetics Market Revenue, 2023-2030 ($M)
13.Italy Cytogenetics Market Revenue, 2023-2030 ($M)
14.Spain Cytogenetics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Cytogenetics Market Revenue, 2023-2030 ($M)
16.China Cytogenetics Market Revenue, 2023-2030 ($M)
17.India Cytogenetics Market Revenue, 2023-2030 ($M)
18.Japan Cytogenetics Market Revenue, 2023-2030 ($M)
19.South Korea Cytogenetics Market Revenue, 2023-2030 ($M)
20.South Africa Cytogenetics Market Revenue, 2023-2030 ($M)
21.North America Cytogenetics By Application
22.South America Cytogenetics By Application
23.Europe Cytogenetics By Application
24.APAC Cytogenetics By Application
25.MENA Cytogenetics By Application
26.Abbott Laboratories, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Agilent Technologies, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Applied Spectrial Imaging, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Empire Genomics, LLC, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Illumina, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Irvine Scientific, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.OPKO Health, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.PerkinElmer, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Sysmex Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Thermo Fisher Scientific, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)